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Abstract: This study aimed to assess the impact of malnutrition on the 5-year evolution of physical
performance, muscle mass and muscle strength in participants from the SarcoPhAge cohort, con-
sisting of community-dwelling older adults. The malnutrition status was assessed at baseline (T0)
according to the “Global Leadership Initiatives on Malnutrition” (GLIM) criteria, and the muscle
parameters were evaluated both at T0 and after five years of follow-up (T5). Lean mass, muscle
strength and physical performance were assessed using dual X-ray absorptiometry, handgrip dy-
namometry, the short physical performance battery test and the timed up and go test, respectively.
Differences in muscle outcomes according to nutritional status were tested using Student’s t-test.
The association between malnutrition and the relative 5-year change in the muscle parameters was
tested using multiple linear regressions adjusted for several covariates. A total of 411 participants
(mean age of 72.3 ± 6.1 years, 56% women) were included. Of them, 96 individuals (23%) were
diagnosed with malnutrition at baseline. Their muscle parameters were significantly lower than those
of the well-nourished patients both at baseline and after five years of follow-up (all p-values < 0.05),
except for muscle strength in women at T5, which was not significantly lower in the presence of
malnutrition. However, the 5-year changes in muscle parameters of malnourished individuals were
not significantly different than those of well-nourished individuals (all p-values > 0.05).
Keywords: malnutrition; GLIM; SarcoPhAge; muscle mass; muscle strength; physical performance
1. Introduction
Physiological changes occur with aging, increasing the risk of poor nutritional sta-
tus [1]. Indeed, older adults are subjected to a decline in the senses of smell and taste and
poor oral health, leading to a loss of appetite and anorexia [1,2]. Polypharmacy, inflamma-
tion and gastrointestinal disorders, which can lead to malabsorption, can also negatively
impact nutritional status [1,2]. Alongside these physiological changes, psychosocial and
environmental changes, namely, loneliness, depression, dementia, anxiety and loss of
independence, may also be significant risk factors for malnutrition [1,2].
Malnutrition represents a major public health concern because of its high prevalence in
the geriatric population and the costs it entails. Its prevalence rate varies widely according
to the assessment tool, the geriatric setting studied or the definition criteria used. However,
it is well recognized that a sizeable proportion of older adults may be malnourished, with
a pooled estimated malnutrition risk prevalence of 22.6% in Europe [3]. Interestingly, in
that meta-analysis using 22 malnutrition screening tools validated for use in older adults,
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the prevalence of malnutrition risk ranged from 8.5% in the community to 28% in the
hospital [3]. Regarding the costs, malnutrition results in an economic burden for both the
public health system and malnourished older individuals. Indeed, in a systematic review
by Abizanda et al., malnutrition was associated with higher use of health care resources
compared to well-nourished individuals, both in institutionalized or community-dwelling
older adults, mainly due to higher general practitioner consultations, health monitoring
and treatments [4].
Until recently, malnourished older adults were frequently under-diagnosed because of
a lack of consensus on the assessment of this syndrome [1]. The first international definition
was launched in 2015 by the European Society of Clinical Nutrition and Metabolism (ES-
PEN) following the action plan towards an optimal ageing described in the World Report on
Ageing and Health [1]. In 2019, a new international agreement regarding the malnutrition
diagnosis criteria was achieved by the worldwide clinical nutrition community, including
the ESPEN society, to develop the Global Leadership Initiative on Malnutrition (GLIM) [5].
Previous studies have suggested that there is a risk of underestimating the malnutrition
prevalence when the ESPEN definition is used [6,7]. Indeed, this definition requires the
association of a weight loss with either a low Body Mass Index (BMI) or a decrease in
muscle mass, while the GLIM phenotypic criteria require only one of the three factors. It
is now well established that each criterion has to be considered separately given the fact
that each of them may be indicative of malnutrition. The GLIM criteria revise and update,
therefore, the previous international malnutrition definition, being partially based on it [8].
These criteria are meant to be applied across global health care sectors with the objective
of standardizing clinical practice and research. Their development is an important step
for the diagnosis of malnutrition in older people. Indeed, malnutrition has been shown to
be associated with increased morbidity and mortality rates [9–11] and impaired quality of
life [12], such as loss of independence in activities of daily living [13].
Interestingly, malnutrition seems to be related to muscle health decline and may
contribute to the development of sarcopenia [14–16] and aggravate the age-associated loss
of muscle mass, muscle strength and physical performance [17,18]. In one of our previous
studies using observations from the SarcoPhAge cohort, we found that malnourished older
individuals had a more than three-fold higher risk of developing sarcopenia after four years
of follow-up than older individuals who were not malnourished [19]. There is growing
evidence that links nutrition to muscle parameters [20]; however, how malnutrition affects
the specific sarcopenia criteria decline remains unknown. Investigating the decline of the
different muscle components in malnourished participants appears important in order to
develop more effectively targeted therapeutic interventions, subsequently resulting in the
prevention or slow-down of the related muscle health decline. Consequently, this study
aimed to evaluate the impact of malnutrition, diagnosed according to the GLIM criteria, on
changes in muscle mass, muscle strength and physical performance over a five-year period
in older community-dwelling individuals.
2. Materials and Methods
This is a post-hoc analysis, as the primary objective of the SarcoPhAge cohort was the
study of sarcopenia. Nevertheless, all the necessary data and measurements for the present
study were already described in the research protocol in 2013.
2.1. Study Population
Participants from the SarcoPhAge (for “Sarcopenia and Physical Impairments with
advancing age”) cohort were included in the present analysis. The detailed methodology
of the SarcoPhAge study has already been described in detail elsewhere [21]. Briefly, the
SarcoPhAge cohort is a Belgian population-based cohort developed in Liège (Belgium)
in 2013. A total of 534 community-dwelling participants aged 65 years and older were
recruited from press advertisements and general, geriatric, osteoporosis, rehabilitation, and
rheumatology departments from an outpatient clinic in Liège, Belgium.
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No specific exclusion criteria related to health or demographic characteristics were
applied, except the exclusion of individuals with an amputated limb or with a BMI above
50 kg/m2, which was required for dual X-ray absorptiometry. The study was approved
by the Ethics Committee of the Teaching Hospital of the University of Liege (reference
2012/277), with two amendments in 2015 and 2018. All volunteers gave their written
informed consent.
The participants were followed up annually, and a clinical research assistant per-
formed physical examinations and heath questionnaires to gather sociodemographic and
anamnestic data.
2.2. Diagnosis of Malnutrition
The diagnosis of malnutrition according to the Global Leadership Initiative on Mal-
nutrition (GLIM) criteria was performed at baseline [5]. The GLIM algorithm implies a
two-step approach with, first, screening using one of the validated tools proposed and,
second, a diagnosis based on three phenotypic and two etiological criteria. The phenotypic
criteria are used further to grade the severity of malnutrition, with specific threshold values
different than those for the diagnosis. Since we had the data needed to diagnose malnu-
trition in all the included participants, the diagnosis could be established for the whole
population. Therefore, we did not apply the screening part of the definition, useful and
required in clinical routine for early identification of malnutrition. Malnutrition severity
was not graded either, because the presence of malnutrition was used as a dichotomous
variable for the objectives of the present study.
The GLIM malnutrition diagnosis requires at least one phenotypic and one etiological
criterion that meet predefined thresholds. Based on the guidance proposed by the GLIM
core leadership committee, the following thresholds were applied in the present study:
- The phenotypic assessment includes (1) an unintentional weight loss higher than
4.5 kg in the past year [22], (2) a body mass index under 20 kg/m2 in participants
younger than 70 years old or 22 kg/m2 in those older than 70 years old [5], and (3) a
reduced muscle mass with a fat-free mass index (FFMI) under 17 kg/m2 in men and
15 kg/m2 in women or an appendicular lean mass index (ALMI) under 7 kg/m2 in
men and 5.5 kg/m2 in women [5,23].
- The etiological assessment involves (1) a reduced food intake determined according
to the first item of the Mini Nutritional Assessment Short-Form (moderate or severe
loss of appetite in the past three months) [24] and (2) inflammation evaluated by
interleukin-6 (IL-6) and insulin-like growth factor 1 (IGF-1) [25], where the highest or
the lowest quartile for IL-6 and IGF1, respectively, calculated in our own data set in
both sexes, was considered a sex-specific threshold (i.e., IGF-1 ≤88 ng/mL in men and
≤82 ng/mL in women and IL-6 >3.84 pg/mL in men and >2.99 pg/mL in women).
Inflammation is highlighted once the value of IL-6 is above or IGF-1 is below these
thresholds. These thresholds are similar to other previous published thresholds for
community-dwelling older adults [26,27]. The biomarkers used in the present study
were identified as relevant for geroscience-guided clinical trials, robust, with a con-
sistent ability to predict clinical and functional outcomes, responsive to intervention,
and with a reliable and feasible measurement according to a comprehensive review
conducted by a panel of experts [25]. From all the biomarkers considered in this
review, IL-6 was selected over CRP for the assessment of inflammation because it was
more robust and considered as more appropriate to reflect the aging process. TNF-α
was not selected for this present study because it tends to be low and unstable when
stored at a temperature of −80 ◦C. Regarding IGF1, this biomarker was selected for its
responsiveness to caloric restriction given the fact that it was used for the diagnosis
of malnutrition.
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2.3. Muscle Parameters
To investigate the muscle health of our participants, three measurements were per-
formed: muscle mass, muscle strength and physical performance.
Physical performance was evaluated using the Short Physical Performance Battery
(SPPB) test, which consisted of three physical assessments: balance, 4-m walking speed,
and the chair stand test [28]. A score between 0 and 4 points was assigned for each of the
three separate tests, with a maximum of 12 points. Physical performance was also assessed
using the timed up and go (TUG) test, where participants were asked to stand up from a
chair, walk three meters, turn around, return, and sit down again [29]. The performance
was timed and reported in seconds.
Muscle mass was estimated with a dual energy X-ray absorptiometer (DXA) (Hologic
Discovery A, USA), calibrated daily. Fat-free mass, that is, the subtraction of fat mass from
total body mass, and appendicular lean mass, the sum of the muscle mass in both arms
and legs, were obtained from whole-body DXA scans and were divided by height squared
(kg/m2) to obtain the fat-free mass index (FFMI) and the appendicular lean mass index
(ALMI) values, respectively.
Muscle strength was measured with a handgrip hand-held dynamometer (Saehan
Corporation, MSD Europe Bvba, Brussels, Belgium), calibrated yearly. We followed stan-
dardized procedures by asking participants to squeeze as hard as possible three times per
hand. The highest value of the six measurements, in kg, was considered [30].
Cut-off values were used to highlight impaired muscle parameters:
• Low physical performance with an SPPB score ≤ 8 points [8] and a TUG score ≥ 20 s [23].
• Low muscle mass with an FFMI under 17 kg/m2 in men and 15 kg/m2 in women or
an ALMI under 7 kg/m2 and 5.5 kg/m2 in men and women, respectively [23].
• Low muscle strength with grip strength under 27 kg and 16 kg in men and women,
respectively [23].
2.4. Confounding Factors
The following variables that could potentially impact muscle health and nutritional
status according to the literature [19,31–37] were considered covariates: age, sex, smoking
status (yes/no), alcohol consumption (yes/no), number of comorbidities per individual,
number of drugs consumed per individual, cognitive status assessed by the Mini-Mental
State Examination (MMSE) [38], self-reported physical activity level with the Minnesota
Leisure Time Activity Questionnaire [39], and the baseline value of the muscle component.
2.5. Statistical Analysis
The distribution of the continuous variables was evaluated by the difference between
the mean and the median values, histogram, quantile-quantile plot, and the Shapiro-
Wilk test. Nevertheless, continuous variables had to be treated and reported following a
Gaussian distribution because of the predictive mean matching method executed in the
multiple imputations procedure [40]. The continuous variables were then expressed as the
mean ± standard deviation, and categorical variables were reported in absolute (N) and
relative frequencies (%).
The prevalence of malnutrition according to the GLIM definition was assessed. Par-
ticipants’ baseline characteristics and muscle parameters at baseline and after five years
of follow-up were compared between malnourished and non-malnourished individu-
als using Student’s t-test for quantitative variables and using the chi-squared test for
qualitative variables.
The changes in muscle mass (FFMI and ALMI), muscle strength (grip strength),
and physical performance (SPPB and TUG tests) were calculated by the relative change
(i.e., difference between the baseline and follow-up values, as a percentage of the baseline
value) from baseline to the fifth year. Relative changes allowed us to consider the effect,
on the 5-year change on the potential large imbalance in the baseline muscle parameters
according to the diagnosis of malnutrition. First, a crude model was performed to compare
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the mean relative changes in the muscle parameters according to malnutrition status using
Student’s t-test for independent data. Then, the association between the relative change
between T0 and T5 of these muscle parameters and malnutrition was determined through
multiple linear regressions with one of the muscle parameters as a dependent variable and
nutritional status as an independent variable, adjusted for confounding factors using the
enter method. A first multivariate analysis model was adjusted for age only for muscle mass
and muscle strength, as the analyses were separated for men and women and adjusted for
age and gender for physical performance. A second model was then performed, adjusted
for all the potential covariates identified above. The baseline value of the muscle component
was also used as a covariate in the fully adjusted model, as we assumed baseline muscle
parameter imbalance according to the diagnosis of malnutrition, which could influence
the possible change range of the muscle parameters during the follow-up. The individuals
with lower baseline values could undergo a larger improvement, and inversely. This
phenomenon, known as regression to the mean, can be taken into account, as well as the
ceiling and floor effects, with this adjustment [41].
The proportion of individuals presenting low muscle parameters according to the
defined thresholds was estimated at baseline and at the fifth year of follow-up. We were
then able to compare, first, the proportion of individuals below the cut-off values in
malnourished and non-malnourished individuals, both at baseline and at the five-year
follow-up, using the chi-squared test. Second, we calculated the change in the proportion
of individuals with low muscle parameters between baseline and the fifth year of follow-up
and compared these changes in proportion according to nutritional status with the two
proportions Z test for independent samples.
Missing data were handled using multiple imputations according to the Markov
chain Monte Carlo model, in which the predictive mean matching method was applied
for continuous variables. Five datasets were computed, and pooled estimates from these
datasets were used to report the analysis results.
The results were considered statistically significant at a degree of uncertainty of 5%
(p < 0.05). The SPSS Statistics 24 (IBM Corporation, Armonk, NY, USA) software package
was used for the analyses.
3. Results
The baseline characteristics of the participants are presented in Table 1. Out of the
534 participants recruited initially in the SarcoPhAge cohort, data needed to diagnose
malnutrition at baseline, according to the GLIM criteria, were available for a total of
411 participants (mean age of 72.3 ± 6.1 years, 56% women). Among these participants,
96 (23.3%) were diagnosed with malnutrition at baseline. The malnourished participants
were significantly more women (p-value < 0.05) and smokers (p-value < 0.01), had a lower
body mass index (23.9 ± 4.0 kg/m2 versus 27.7 ± 4.5 kg/m2, p-value < 0.001), had more
concomitant diseases (5.0 ± 2.4 versus 4.0 ± 2.3, p-value < 0.001), and had a worse cognitive
status (27.6 ± 2.3 versus 28.2 ± 2.0 out of 30 points on the MMSE scale, p-value = 0.01) than
the well-nourished participants.
When looking at the muscle parameters according to nutritional status (Table 2), the
malnourished individuals had a significantly lower SPPB test score, took more time to
perform the TUG test, had less fat-free mass and appendicular lean mass, and had a lower
muscle strength compared to well-nourished individuals, in both men and women and at
baseline but also at the end of the five years of follow-up (all p-values being under 0.05).
The only exception was that muscle strength in malnourished women was not significantly
lower than that in well-nourished women at the five-year follow-up (p-value = 0.99).
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Yes (n = 96) No (n = 315)
Age, years 73.2 ± 6.1 73.9 ± 6.8 73.0 ± 5.8 0.19
Gender
0.046Men 182 (44.8) 34 (35.4) 148 (47.0)
Women 229 (55.7) 62 (64.6) 167 (53.0)
Smoking status, yes 33 (8.0) 14 (14.6) 19 (6.0) 0.007
Alcohol consumption, yes 215 (52.3) 54 (56.3) 161 (51.1) 0.38
Body mass index, kg/m2 26.8 ± 4.7 23.9 ± 4.0 27.7 ± 4.5 <0.001
Number of concomitant diseases
per individual 4.2 ± 2.4 5.0 ± 2.4 4.0 ± 2.3 <0.001
Number of drugs per individual 5.8 ± 3.4 6.3 ± 3.5 5.6 ± 3.4 0.059
Mini-Mental State Examination
(MMSE), 30 points 28.1 ± 2.1 27.6 ± 2.3 28.2 ± 2.0 0.012
Level of physical activity, kcal/day a 1102.9 ± 1257.8 1057.3 ± 1267.9 1116.7 ± 1256.4 0.68
Quantitative variables were expressed as mean (standard deviation), and binary or categorical variables were described by absolute (n) and
relative (%) frequencies. a This variable did not follow a Gaussian distribution. but we had reported it as following a Gaussian distribution
because of the predictive mean matching method executed in the multiple imputations procedure. b p-values obtained from a Student’s
t-test for quantitative variables and a chi-squared test for qualitative variables.














Men 16.8 ± 2.2 19.3 ± 2.3 <0.001 16.7 ± 2.1 18.4 ± 2.2 <0.001




Men 7.0 ± 1.0 8.2 ± 1.0 <0.001 6.9 ± 1.0 7.6 ± 1.0 0.005
Women 5.5 ± 0.7 6.3 ± 1.0 <0.001 5.9 ± 0.9 6.3 ± 0.8 0.002
Grip strength, kg
Men 32.5 ± 10.1 40.8 ± 7.8 <0.001 22.6 ± 9.5 30.7 ± 9.0 0.045




8.4 ± 2.8 9.7 ± 2.0 <0.001 8.8 ± 2.5 9.9 ± 1.9 0.001
Timed up and go
(TUG), s 13.4 ± 7.3 11.0 ± 4.9 <0.001 12.4 ± 6.5 9.9 ± 4.0 0.001
* p-values obtained from a Student’s t-test.
The relative changes over five years are presented in Table 3 for muscle mass and
muscle strength and in Table 4 for physical performance. In the univariate analyses, the
results showed a significant difference between well-nourished and malnourished older
adults in the relative change over five years of the FFMI and the ALMI only, both in men
and women (all p-values < 0.05). These results remained significant in the first adjusted
model including age as a covariate (all p-values < 0.05) but not in the fully adjusted model.
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Indeed, when adjusted for all covariates, the relative changes in all muscle parameters
(namely, FFMI, ALMI, muscle strength, SPPB and the TUG test) over five years of follow-up
did not differ significantly according to nutritional status (p-value > 0.05).
Table 3. Relative change over time of muscle mass and muscle strength over a five-year period according to nutritional
status and gender (n = 411).
Crude Model Model 1 Model 2
Relative Change
T0–T5 (%) p-Value * p-Value ** p-Value ***














−23.5 ± 48.3 0.96 0.94 0.55














−26.8 ± 33.1 0.46 0.45 0.45
* p-values obtained from a Student’s t-test ** p-values obtained from multiple linear regression adjusted for age *** p-values obtained from
multiple linear regression adjusted for age, smoking status, alcohol consumption, number of comorbidities, number of drugs consumed,
MMSE, Physical activity level and baseline value of the muscular component.
Table 4. Relative change over time of physical performance over a five-year period according to the nutritional status
(n = 411).
Crude Model Model 1 Model 2
Relative Change










−1.9 ± 3.8 0.40 0.24 0.12
* p-values obtained from a Student’s t-test ** p-values obtained from multiple linear regression adjusted for age and gender *** p-values
obtained from multiple linear regression adjusted for age, smoking status, alcohol consumption, number of comorbidities, number of drugs
consumed, MMSE, Physical activity level and baseline value of the muscular component.
The variability of the dependent variables (i.e., muscle parameters) that was explained
by the independent variables included in the models, which is represented by the R2, was
at least three times higher in the second model compared to the first for each outcome
assessed. Furthermore, when we explored the effect of each confounding variable on the
dependent variable (i.e., the muscle parameter), the baseline value of the parameter was
the only significant variable in the model for all the muscle parameters. This means that
this confounding variable included in the second model explains, at least partially, the
non-significant changes observed between malnourished and well-nourished individuals.
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The proportion of individuals with muscle parameters below the threshold, presented
in Table 5, was significantly higher in the malnutrition group at T0 and T5 (p-values < 0.05).
Only the proportion of individuals with low muscle strength was not significantly different
at the fifth year of follow-up according to nutritional status (55.0% vs. 45.2%, p = 0.11).
Table 5. Low muscle mass, muscle strength and physical performance at T0 and T5 and the change in the proportion of




















































* Indicates a significant change in the five-year prevalence of low muscle parameters between malnourished and well-nourished patients.
Globally, the number of individuals below the threshold values was lower at the
five-year follow-up than at baseline, both in malnourished and well-nourished individuals,
except for muscle strength. For this last parameter, an important increase in the proportion
of older individuals reaching this cut-off was observed after five years of follow-up. Re-
garding the change in the prevalence of subjects below the threshold between T0 and T5,
the difference was non-significant according to malnutrition status, except for the FFMI
and ALMI (p-values < 0.05).
4. Discussion
In our analyses, malnourished individuals had globally weaker muscle mass, muscle
strength and physical performance than well-nourished individuals, both at baseline and
at five years follow-up. Similar conclusions are drawn when the thresholds of low muscle
parameters are applied, as the proportion of individuals reaching these thresholds is more
important in malnourished than in well-nourished individuals at the two same time points.
However, the evolution of the muscle parameters after five years did not seem to be
impacted by malnutrition in the present study. Indeed, the five-year changes in all the
muscle parameters were not significantly different according to nutritional status after
adjustment for covariates. Regarding the change in the prevalence of individuals below
thresholds between T0 and T5, the difference was non-significant according to malnutrition
status except for muscle mass (i.e., FFMI and ALMI), in which an improvement was seen
in the number of individuals reaching these thresholds in the malnourished participants
compared to the well-nourished participants (p < 0.05).
The cross-sectional association between malnutrition and muscle health, as observed in
the present study, has already been identified in other studies using different malnutrition
criteria than the GLIM ones, the GLIM definition being very recent. In the study of Liguori
et al., similar results to ours were observed for muscle mass and strength, which were
negatively associated with the risk of malnutrition, assessed using the mini-nutritional
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assessment (MNA) questionnaire, in non-institutionalized older adults [42]. Moreover, a
negative association between physical performance and malnutrition was found in the
research of Ramsey et al., in which malnourished geriatric outpatients, assessed by the
Short Nutritional Assessment Questionnaire (SNAQ), had lower SPPB and higher TUG
scores than well-nourished patients (p < 0.05) [43]. However, no significant association
between malnutrition and handgrip strength was found in this study, as opposed to our
results and those of Liguori et al. The divergence regarding muscle strength can potentially
be explained by the use of different malnutrition criteria. Indeed, the MNA and the
SNAQ questionnaires are recommended for the screening part of the definition, a first
step before the diagnosis of malnutrition assessed by the GLIM criteria in the present
study. Furthermore, it has been shown that dissimilar criteria could identify different
patients in the same population [44] and that the MNA itself may overestimate the risk of
malnutrition in geriatric rehabilitation settings [45] and in hospitalized older adults [46].
Interestingly, the GLIM definition itself includes low muscle mass as a phenotypic criterion.
It seems therefore coherent that individuals diagnosed with malnutrition had lower muscle
health in our study. The cross-sectional link between nutrition and muscle health is well
established because nutritional strategies are now an integral part of the prevention and
management of sarcopenia [47].
Regarding the impact of malnutrition on the five-year change in muscle parameters,
we are the first, to our knowledge, to have investigated it with the GLIM criteria in
community-dwelling older adults. In a previous study using data from our SarcoPhAge
cohort, individuals diagnosed with malnutrition by the GLIM criteria, had a three-fold
increased risk of becoming sarcopenic compared with well-nourished individuals after
four years of follow-up [19]. Therefore, this study aimed to explore these results further
by analyzing the impact of malnutrition on each specific muscle parameter. The results
of the present study revealed, surprisingly, that the relative changes in muscle mass,
muscle strength and physical performance did not differ according to nutritional status.
We can presume that the possible range in decline of muscle parameters was smaller,
and muscle parameters were subjected to floor effects [48], especially as observed for
muscle strength at five-year of follow-up in women. In fact, malnourished individuals
had lower muscle baseline values than well-nourished individuals. Similarly, in a study
by Goodpaster et al., examining the three-year changes in knee extensor strength in older
adults, it was found, as in the present study, that those who were stronger at baseline were
more likely to lose more strength during follow-up, whether change data were expressed
in absolute or proportionate changes, and this phenomenon was observed for both men
and women [49]. In the present study, the baseline value of the muscle parameter was
included in the fully adjusted model. When we explored the effect of each covariate on
the dependent variable (i.e., the muscle parameter) in the model, the baseline value of
the parameter appeared to be significant for all the muscle parameters. This means that
the baseline value of the muscle parameters explains, at least partially, the non-significant
changes observed between malnourished and well-nourished individuals and supports
the hypothesis developed above.
The number of older adults below the thresholds of muscle mass and physical per-
formance has decreased in five years, especially in malnourished patients, which is quite
unexpected. Nevertheless, the mean of these parameters in malnourished patients at
baseline was close to the threshold values. Therefore, we can assume that the transition
towards and away from the low muscle parameter group could have been made even with
a small change, potentially non-clinically pertinent. In other words, this result highlights
the relevance of measuring the minimal clinically important difference (MCID), instead
of threshold values, when evaluating evolution over time. Indeed, even if fewer older
adults had a low muscle mass or physical performance at five years of follow-up, this
does not mean that the improvement observed is relevant, for the patients or clinically.
Currently, the MCID for muscle strength, the SPPB or the TUG test can be found in the
literature [48], but it is still not well defined in older adults and clinical practice, as the
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values can vary widely according to the calculation method used or the population tar-
geted. Furthermore, the MCID is context-dependent, is influenced by the health state of the
patients and their demographic characteristics [50] and is baseline value-dependent [51],
as patients with lower scores at inclusion required more change to report a meaningful
difference. Therefore, we could not apply MCID values in this study, as additional research
is needed to harmonize the recommendations. Nevertheless, this could provide consid-
erable information regarding changes in muscle parameters. From a statistical point of
view, the changes appeared to be non-significant according to nutritional status, but from
the patients’ perspective, these changes could potentially have dissimilar repercussions on
their global health status or quality of life in the presence or absence of malnutrition.
While there did not appear to be any major differences in the number of subjects
reaching the threshold values regarding muscle mass and physical performance after five
years of follow-up, this was not the case for muscle strength. The number of patients below
the cut-offs more than doubled after five years, which is probably the leading cause of the
increased incidence of sarcopenia observed in our previous study [19]. Muscle strength is
also the parameter that underwent the most important relative difference of all the muscle
parameters. First, muscle strength was the furthest parameter from the threshold value at
baseline compared to muscle mass or physical performance. Therefore, we can assume that
the possible range of decrease was higher for muscle strength. Second, this parameter has
already been identified as a responsive component of muscle health, as the age-associated
decline in muscle strength is more rapid than muscle mass loss, with an annual rate three
to five times higher than muscle mass in healthy older adults [49,52]. Moreover, muscle
strength is now considered the principal determinant of sarcopenia, as it is recognized as the
best parameter in predicting adverse outcomes [23]. Finally, contrary to our expectations
and the literature [2,18,53,54], muscle mass underwent a limited decrease, even an increase
in the ALMI in women, and physical performance improved in our analyses after five
years of follow-up. In a previous study of the SarcoPhAge cohort [55], we noticed a
significant increase in the level of physical activity after three years of follow-up. The
increase in physical activity level, which is associated with better muscle health [56–59],
could explain, to a certain extent, the evolution observed for these two muscle parameters
in the present study.
Strengths and Limitations
The present study has several limitations that can be underlined. First, the constitution
of our population has potentially brought a selection bias, as they are recruited volunteers.
Furthermore, the malnutrition prevalence of 23.4% in our cohort appeared to be higher
than the prevalence of 10.7% and 14% found in other studies using the GLIM criteria in
community-dwelling older adults [60,61]. Consequently, our results could be limited in
their external validity. Second, the length of follow-up, which was five years, was probably
not long enough to highlight an evolution significantly different according to nutritional
status, especially for muscle mass. Last, nutrition is not the only factor that can impact
muscle health. Resistance and aerobic exercise training are also known to play a positive
role in the management of muscle health decline [62] by enhancing myofibrillar protein
synthesis [63]. The analyses were adjusted for physical activity level, but we did not adjust
for the type of physical activity because we did not have the data. The participants could
also have benefited from a nutritional intervention during the five-year follow-up, such
as nutritional supplementation, and this could have impacted the outcomes measure by
improving the muscle parameters or, at least, slowing their decrease [64,65]. Unfortunately,
this potential confounding variable was not assessed in this cohort.
Regarding the criteria and threshold values used in the present study to diagnose mal-
nutrition, these were chosen according to the recommended propositions from the GLIM
consensus, except for the unintentional weight loss criteria from the FRIED questionnaire,
as we did not have any other available data. However, details of how to categorize each
criteria are not yet provided, as evidence on clear threshold values are lacking [66]. For
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example, the GLIM consensus report indicates that the thresholds for the “reduced food
intake” and “weight loss” criteria are widely reported in the literature and vary according
to the malnutrition tool used [5]. This is also the case for inflammation, for which clear
measurement methods or threshold values are not communicated in the GLIM definition.
This could lead to variations in the proportion of malnourished individuals across studies,
e.g., a prevalence of 10.7% found in a study of Yeung et al., applying different measures
and thresholds for the GLIM criteria [60] than in the present study. Nevertheless, this
highlights the need for a consensus regarding the assessment of the different malnutrition
criteria and brings new research perspectives to identify the thresholds that are most pre-
dictive of adverse outcomes. Regarding the strengths of this study, multiple imputations
were carried out to handle missing data. Nevertheless, sensibility analyses performed
without imputations on data available from 224 participants assessed at T5 showed similar
results (data not shown, available on request). This assesses the robustness of our present
findings. In addition, this study produced original results by being the first to investigate
the impact of malnutrition, diagnosed with the GLIM definition, on five-year changes in
muscle mass, muscle strength and physical performance. Therefore, this study brings new
elements to the management of muscle health decline and its relationships with malnutri-
tion. Other studies are therefore required to confirm our findings. Some perspectives could
also be interesting in future studies: investigating the impact of severe malnutrition on
muscle health and adopting a dynamic approach by measuring the cumulative incidence
of malnutrition or the transition of the participants from malnourished to well-nourished
status (i.e., the natural course of the disease) during the follow-up period would allow a
better understanding of the complex mechanisms of malnutrition and its relationship with
health decline.
5. Conclusions
In conclusion, individuals diagnosed with malnutrition had weaker muscle mass,
muscle strength and physical performance than well-nourished individuals in the cross-
sectional analyses. However, after five years, there did not seem to be any difference in
the evolution of the muscle parameters according to nutritional status. Furthermore, in
the present study, muscle strength decline seemed to be the major leading cause of the
incidence of sarcopenia in the SarcoPhAge cohort.
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